We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$905M
AUM Growth
-$6.65M
Cap. Flow
+$9.3M
Cap. Flow %
1.03%
Top 10 Hldgs %
52.46%
Holding
657
New
198
Increased
119
Reduced
86
Closed
223

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$67.4M
2
PFE icon
Pfizer
PFE
+$65.6M
3
APTV icon
Aptiv
APTV
+$29.7M
4
MRNA icon
Moderna
MRNA
+$22.6M
5
CRM icon
Salesforce
CRM
+$19.6M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$85.2M
2
RUN icon
Sunrun
RUN
+$64.1M
3
TPIC
TPI Composites
TPIC
+$31.4M
4
MSFT icon
Microsoft
MSFT
+$30.9M
5
AMZN icon
Amazon
AMZN
+$30.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.6%
2 Healthcare 14.17%
3 Technology 11.37%
4 Financials 4.47%
5 Communication Services 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
F icon
326
CALL
Ford
F
$55.8B
$283K 0.03%
20,000
– –
TDS icon
327
Telephone and Data Systems
TDS
$3.84B
$283K 0.03%
+14,528
New +$302K
GVA icon
328
Granite Construction
GVA
$5.51B
$282K 0.03%
+7,118
New +$281K
AMD icon
329
Advanced Micro Devices
AMD
$767B
$281K 0.03%
2,730
-119,557
-98% -$12.2M
CHDN icon
330
Churchill Downs
CHDN
$6.02B
$281K 0.03%
+2,342
New +$238K
PDM
331
Piedmont Realty Trust
PDM
$1.16B
$281K 0.03%
16,104
– –
UPBD icon
332
Upbound Group
UPBD
$1.12B
$280K 0.03%
4,983
+738
+17% +$43.4K
ASTE icon
333
Astec Industries
ASTE
$991M
$277K 0.03%
+5,140
New +$304K
NEOG icon
334
Neogen
NEOG
$2.49B
$277K 0.03%
+6,373
New +$277K
SLP icon
335
Simulations Plus
SLP
$371M
$277K 0.03%
+7,012
New +$320K
SC
336
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$276K 0.03%
6,628
-24,132
-78% -$993K
HONE
337
DELISTED
HarborOne Bancorp
HONE
$275K 0.03%
19,582
– –
BAH icon
338
Booz Allen Hamilton
BAH
$9.37B
$273K 0.03%
3,445
+470
+16% +$39.3K
TW icon
339
Tradeweb Markets
TW
$21.9B
$272K 0.03%
+3,369
New +$291K
ADVM
340
DELISTED
Adverum Biotechnologies
ADVM
$271K 0.03%
12,485
+9,663
+342% +$247K
HIW icon
341
Highwoods Properties
HIW
$3.41B
$270K 0.03%
+6,152
New +$282K
DVAX
342
DELISTED
Dynavax Technologies
DVAX
$268K 0.03%
+13,960
New +$185K
ANF icon
343
Abercrombie & Fitch
ANF
$5.27B
$267K 0.03%
7,106
-7,033
-50% -$272K
VRS
344
DELISTED
Verso Corporation
VRS
$265K 0.03%
12,752
– –
FSK icon
345
FS KKR Capital
FSK
$3.37B
$264K 0.03%
11,981
-17,837
-60% -$394K
MMSI icon
346
Merit Medical Systems
MMSI
$5.36B
$262K 0.03%
+3,648
New +$248K
ACBI
347
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$261K 0.03%
9,834
– –
KFY icon
348
Korn Ferry
KFY
$4.25B
$260K 0.03%
3,598
+423
+13% +$29.5K
DOV icon
349
Dover
DOV
$28.3B
$257K 0.03%
+1,655
New +$274K
GS icon
350
Goldman Sachs
GS
$301B
$257K 0.03%
+681
New +$266K
12 13
14
15 16

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q3 2021 Portfolio in Review

As of Q3 2021, Caxton Associates (New York) held 657 positions worth $905M, down 0.73% from $912M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Caxton Associates (New York)'s Q3 2021 filing shows 198 new, 119 increased, 86 reduced and 223 closed positions. Its largest new stake was Pfizer: 1,480,000 shares worth $63.7M. The largest sale was Baidu, an estimated $85.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • Caxton Associates (New York)'s largest Q3 2021 buy was Pfizer: 1,480,000 shares worth $63.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2021, an estimated $67.4M increase.
  • Caxton Associates (New York)'s biggest Q3 2021 reduction was Sunrun, cutting an estimated $64.1M.
  • Caxton Associates (New York) fully exited Baidu in Q3 2021, selling an estimated $85.2M.
  • Caxton Associates (New York)'s ten largest holdings make up 52% of its $905M portfolio in Q3 2021.
  • Caxton Associates (New York) opened 198 new positions and closed 223 in Q3 2021.
  • Caxton Associates (New York)'s portfolio value fell 0.73% quarter-over-quarter to $905M.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.